Actively Recruiting
Evaluating Clinical and Radiographic Outcomes of PRIMA Humeral Stem in Total Shoulder Replacement
Led by Limacorporate S.p.a · Updated on 2026-08-12
60
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are studying outcomes after total shoulder replacement surgery using the PRIMA humeral stem implant. This includes patients receiving either an anatomic or reverse shoulder replacement. The study aims to assess clinical, radiographic, and patient-reported results up to 24 months after surgery, focusing on short-term implant performance, survivorship, and complications. Participants have undergone shoulder arthroplasty with the PRIMA humeral stem in either anatomic or reverse configuration according to standard procedures. The study collects data on these surgeries and follows patients for up to 24 months to monitor changes in shoulder function, implant stability, and adverse events. During the study, participants will have assessments including the Constant Murley Score, American Shoulder and Elbow Surgeons score, range of motion measurements, and radiographic evaluation of the implant. Researchers will also track implant survival rates and record any complications or device-related adverse effects. Follow-up visits occur over two years to collect this information and evaluate overall outcomes.
CONDITIONS
Brief Title
PRIMA EU Retrospective & Prospective
Research Team
C
Camilla Vianello
F
Francesca Citossi
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
